Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort
Professor Jean-Yves Blay and Professor Florence Duffaud
14 Nov 2019
D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk ...
Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands
25 Sep 2019
A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple my...
Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA
25 Sep 2019
Synthesis, preclinical analysis, and first-inhuman phase I imaging of 89Zr-DFOda...
Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA
25 Sep 2019
Comparative effectiveness of lenalidomide, bortezomib, and their combinations fo...
Dr Peter Barth - Rhode Island Hospital, Philadelphia, USA
25 Sep 2019
Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
25 Sep 2019
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
25 Sep 2019
Real-world use of carfilzomib therapy among patients with existing cardiovascula...
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
25 Sep 2019
Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma pati...
Dr Charlotte Pawlyn - Royal Marsden Hospital, London, UK
25 Sep 2019
HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients wi...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
25 Sep 2019
Iberdomide in combination with dexamethasone for multiple myeloma
Prof Sagar Lonial - Winship Cancer Institute, Atlanta, USA
25 Sep 2019
First results of the GMMG-CONCEPT trial for multiple myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
25 Sep 2019
